|
<a href=https://doxycycline.world/>side effects of doxycycline monohydrate</a> Heterogeneity in study approaches in terms of definition of subtypes using full ER, PR, or HER2 status v ER PR status alone, in handling of BMI in statistical analyses categorical with two v three categories v continuous; handling BMI as a continuous variable will enhance power, and in definitions of outcomes breast cancer or overall mortality and in treatments received anthracycline v nonanthracycline chemotherapy may all contribute to inconsistent findings |
|